Illumina files patent dispute with BGI | LabPulse.com
Illumina Owes BGI $333.8 Million Over Gene-Sequencer Patents (2)
Illumina wins UK round of global patent battle against BGI | Business Weekly | Technology News | Business news | Cambridge and the East of England
Illumina Pays To Settle Years-Long Patent Battles - Competition Policy International
A $325M Patent - 2 Color SBS - by Nava Whiteford
Complete Genomics Sues Illumina for Antitrust and Unfair Competition Violations
Firm behind mass testing hit by lawsuit | The Standard
Illumina Settles BGI Patent Battles For $325M :: Medtech Insight
Illumina eyes its next move after jury hands down $334 million patent infringement verdict - The San Diego Union-Tribune
A $325M Patent - 2 Color SBS - by Nava Whiteford
Illumina sets aside $453M to prep for potential EU fines over Grail acquisition
Illumina Wins Patent Infringement Suit against BGI in the UK
Illumina Files Additional Patent Infringement Suit Against BGI in the U.S.
Illumina Wins Patent Infringement Suit against BGI in the UK | Business Wire
BGI Group units, Illumina settle U.S. lawsuits over DNA sequencing | Reuters
BGI Group - Wikipedia
China's BGI says it can sequence a genome for just $100 | MIT Technology Review
Coming of age: ten years of next-generation sequencing technologies | Nature Reviews Genetics
BGI's Gene Sequencer Spin-Off Approved for Shanghai IPO - Caixin Global
Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case | Reuters
Illumina ordered to pay BGI subsidiary $333 million in DNA-sequencing patent case | Reuters
Illumina Settles US Lawsuit by Agreeing to Pay Unit of China's BGI Group USD325 Million
Hoffmann Eitle and MGI prevail as Boards of Appeal revoke Illumina patent - JUVE Patent
Complete Genomics, Illumina settle all patent suits
Illumina and BGI Clash over Patent in German Court
